Han-Kwang YANG, MD, PhD, FACS, Hon ASA, Hon ESA & Hon JSES
Professor, Department of Surgery, at Seoul National Univ. Hospital & Seoul National Univ. College of Medicine
Director, Cancer Hospital, Seoul National University Hospital.

Dr. Yang is involved in several large scale RCT’s for gastric cancer treatment. He was Korean PI of REGATTA study (Phase III study for the role of gastrectomy in stage IV gastric cancer with a single incurable factor; a collaboratory study between JCOG and KGCA). He is investigators of CLASSIC trial, KLASS trials as well as the Korean PI of a phase II study for the role of neoadjuvant imatinib treatment in large gastric GIST (a collaborator study between Japan and Korea). He is the founding chairman of KLASS (Korean Laparoscopic Gastrointestinal Surgery Study Group). His translational research interests are gastric carcinogenesis, DDS, familial gastric cancer, biomarkers and developing PDX model for gastric cancer. He is Chairman of Board of Directors, Korean Cancer Association, Secretary General Elect of IGCA, Honorary fellow of American Surgical Association, Honorary member of European Surgical Association, Honorary International Fellow of Japanese Society of Endoscopic Surgery and a member of Korea Korean Academy of Science and Technology (KAST). He is editor or editorial member of ‘Gastric Cancer’ (the official journal of International Gastric Cancer Association), Asian Journal of Endoscopic Surgery, Annals of Surgery etc. Dr. Yang gave over 300 invited lectures to international meetings and oversea institutes with occasional live demonstration of gastrectomy (open, laparoscopic or robotic).